• Explore /
  • Poster
  • / FOENIX-101: A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring <em>FGFR2</em> gene rearrangements.

FOENIX-101: A phase II trial of TAS-120 in patients with intrahepatic cholangiocarcinoma harboring FGFR2 gene rearrangements.

Abstract Poster

Authors

null

Lipika Goyal

Massachusetts General Hospital, Boston, MA

Lipika Goyal , Rastilav Bahleda , Junji Furuse , Juan W. Valle , Markus Hermann Moehler , Do-Youn Oh , Heung-Moon Chang , Robin Kate Kelley , Milind M. Javle , Mitesh J. Borad , Li-Tzong Chen , Nataliya Volodymyrivna Uboha , Heinz-Josef Klumpen , Peter J. O'Dwyer , Daneng Li , Chigusa Morizane , Jerry Huang , John A. Bridgewater

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2019 Gastrointestinal Cancers Symposium

Session Type

Trials in Progress Poster Session

Session Title

Trials in Progress Poster Session B: Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Track

Cancers of the Pancreas, Small Bowel, and Hepatobiliary Tract

Sub Track

Multidisciplinary Treatment

Clinical Trial Registration Number

NCT02052778

Citation

J Clin Oncol 37, 2019 (suppl 4; abstr TPS468)

DOI

10.1200/JCO.2019.37.4_suppl.TPS468

Abstract #

TPS468

Poster Bd #

Q7

Abstract Disclosures

Similar Posters

First Author: Juan W. Valle

First Author: Andrea Cercek

First Author: Zachary Risch

First Author: Teresa Macarulla